Patents-Review.com
ClassID:

96190 ⎘

C07F9/65312 - CPC Classification

Classification description:

Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms; Five-membered rings containing two nitrogen atoms having the two nitrogen atoms in positions 1 and 2

Recent Application in this class:
#1
20260055126
2026-02-26

SMALL MOLECULE COMPOUNDS WITH PHOSPHORYLATED ARYL STRUCTURES AND USE THEREOF

 #2
20240122951
2024-04-18

METHOD TO TREAT LIPID DYSREGULATION BY MODULATING ACTIVITY OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) PROTEIN WITH SMALL MOLECULE LIGANDS

 #3
20230096149
2023-03-30

Reagents Useful for Synthesizing Rhodamine-Labeled Oligonucleotides

 #4
20210309678
2021-10-07

Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same

 #5
20210275551
2021-09-09

Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands

 #6
20200270287
2020-08-27

Reagents useful for synthesizing rhodamine-labeled oligonucleotides

 #7
20200253995
2020-08-13

Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands

 #8
20190358248
2019-11-28

Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity

 #9
20180303856
2018-10-25

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

 #10
20180303855
2018-10-25

Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity

 #11
20170362260
2017-12-21

Neprilysin inhibitors

 #12
20170246196
2017-08-31

Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity

 #13
20160263132
2016-09-15

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

 #14
20160137616
2016-05-19

Bicyclic 1,3,4-oxadiazole derivatives as sphingosine-1-phosphate receptors' modulators

 #15
20160090393
2016-03-31

Neprilysin inhibitors

 #16
20150376429
2015-12-31

Production process for self-dispersible pigment, self-dispersible pigment, ink, ink cartridge and ink jet recording method

 #17
20150166590
2015-06-18

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

 #18
20140349972
2014-11-27

Substituted pyrimidines

 #19
20140326981
2014-11-06

Heteroleptic copper complexes for optoelectronic uses

 #20
20140128348
2014-05-08

1,3,4-Oxadiazoles-2-thio derivatives as sphingosine-1 phosphate receptors modulators

 #21
20140080705
2014-03-20

N-(1,3,4-oxadiazol-2-yl)arylcarboxamides and use thereof as herbicides

 #22
20130330365
2013-12-12

Neprilysin inhibitors

 #23
20130157982
2013-06-20

Compounds as receptor modulators with therapeutic utility

 #24
20120270842
2012-10-25

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

 #25
20100009936
2010-01-14

CHEMICAL COMPOUNDS

 #26
20080096938
2008-04-24

Sphingosine-1-phosphate (SIP) receptor agonists

 #27
20080071070
2008-03-20

Reagents useful for synthesizing rhodamine-labeled oligonucleotides

 #28
20070293675
2007-12-20

Inhibitors of β-lactamase

 #29
20060275636
2006-12-07

Fuel cell membrane containing zirconium phosphate

 #30
20060223866
2006-10-05

Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity

 #31
20060135483
2006-06-22

Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatases

 #32
20060105999
2006-05-18

Novel inhibitors of beta-lactamase

 #33
20050043276
2005-02-24

Inhibitors of β-lactamase